文献速递肝胆胰外科胃肠外科

腹腔镜切除联合消融治疗多发结直肠癌肝转移的多中心倾向匹配分析

Laparoscopic resection combined with ablation for multiple colorectal liver metastases: a multicentre propensity-matched analysis.
PubMed 文献 · Surg Endosc · 2025-08-13

该多中心倾向匹配分析纳入2018至2023年三个中心接受腹腔镜切除的多发结直肠癌肝转移患者218例,其中67例(30.7%)行腹腔镜联合消融与切除(CARe),151例(69.3%)行单纯腹腔镜切除。倾向匹配后每组49对,两组术后并发症率相似(P=0.964),中位无复发生存期(11.8 vs. 12.1个月,P=0.759)和总生存期(未达到,P=0.656)均无显著差异。结论认为腹腔镜CARe可作为多发CRLM的有用治疗策略。

要点

  • 腹腔镜CARe与单纯腹腔镜切除治疗多发CRLM的术后并发症率相似。
  • 两组中位RFS和OS均无显著差异。
  • ≥4个CRLM、同时性转移与RFS独立相关,双叶分布与OS独立相关。

核心结论

  • 腹腔镜CARe可作为多发结直肠癌肝转移的有用治疗策略。

研究设计与样本

  • 多中心倾向匹配分析,纳入2018至2023年三个中心接受腹腔镜切除的多发CRLM患者218例,其中CARe组67例(30.7%),单纯切除组151例(69.3%),倾向匹配后每组49对。

主要发现

  • 倾向匹配后两组术后并发症率相似(P=0.964)。
  • 两组中位RFS(11.8 vs. 12.1个月,P=0.759)和OS(未达到,P=0.656)无显著差异。
  • 多因素分析显示≥4个CRLM(HR=1.86,95%CI 1.09-3.15,P=0.022)和同时性转移(HR=2.00,95%CI 1.21-3.31,P=0.007)与RFS独立相关。
  • 双叶分布(HR=3.20,95%CI 1.04-9.82,P=0.042)与OS独立相关。
  • 两组复发时间(P=0.666)、复发部位(P=0.279)及复发后治疗(P=0.641)均无统计学显著差异。

临床怎么用

  • 对于多发CRLM,腹腔镜CARe可作为单纯腹腔镜切除之外的备选策略,短期安全性和长期生存与单纯切除相当。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laparoscopic resection is the standard treatment for resectable colorectal liver metastases (CRLM). While the safety profile using combined ablation and resection (CARe) to treat CRLM has been documented, its efficacy has not been compared with that of resection alone in the laparoscopic setting. The aim of this study was to compare the short- and long-term outcomes of laparoscopic CARe with those of laparoscopic resection alone for multiple CRLM. METHODS: Patients with multiple CRLM who underwent laparoscopic resection at three medical centres from 2018 to 2023 were included. Perioperative and oncological outcomes were compared between the two groups. Propensity score matching (PSM) was performed. RESULTS: Of the 218 included patients, 67 (30.7%) underwent laparoscopic CARe, and 151 (69.3%) underwent laparoscopic resection alone. After PSM, 49 matched pairs of patients were included for each group. The postoperative complication rate was similar between the two groups (P = 0.964). The median recurrence-free survival (RFS) (11.8 vs. 12.1 months, P = 0.759) and overall survival (OS) (not reached, P = 0.656) were not significantly different between the two groups. Multivariate analysis revealed that ≥ 4 CRLM [hazard ratio (HR) = 1.86, 95% confidence interval (CI) 1.09-3.15, P = 0.022] and synchronous metastases (HR = 2.00, 95% CI 1.21-3.31, P = 0.007) and was independently associated with RFS, whereas bilobar distribution (HR = 3.20, 95% CI 1.04-9.82, P = 0.042) was independently associated with OS. No statistically significant differences were observed in the timing of recurrence (P = 0.666), the site of recurrence (P = 0.279), or the treatment administered after recurrence (P = 0.641) between the two groups. CONCLUSIONS: Laparoscopic CARe may be considered as a useful treatment strategy for multiple CRLM.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Song H, Li Z, Zhang S, et al. Laparoscopic resection combined with ablation for multiple colorectal liver metastases: a multicentre propensity-matched analysis. Surg Endosc. 2025. PMID: 40801919. doi:10.1007/s00464-025-12040-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。